Health

Health ·

Hong Kong registers chronic hives medicine as ‘1+’ drug approvals reach 22

The medicine had already been approved by a US drug regulatory authority and was judged by Hong Kong authorities to meet safety, efficacy and quality requirements.

Read the story
Cut-paper diagram of a generic medicine package moving through a Hong Kong registration gateway, as an external regulatory approval and local data-review documents converge under a prominent “1+” marker; 22 small approval tiles form an arc beside the route.

Latest

More news · newest first

More in Health

English coverage informed by local Chinese-language reporting. Original sources linked in every story.